Danyelza 40mg 40mg/10ml Vials

Danyelza 40mg

Active Ingredient:
Naxitamab
Form:
Vials
Brand:
Danyelza 40mg
Origin:
USA

Buy Danyelza 40mg Naxitamab

Danyelza 40mg (naxitamab) is a prescription medication used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of relapsed or refractory high-risk neuroblastoma in pediatric patients. This sterile, preservative-free solution comes in 40mg/10ml vials for intravenous use. Store between 2-8°C to maintain potency.

Strength

40mg/10ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Y-Mabs Therapeutics inc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Naxitamab is primarily used to treat children with neuroblastoma that has returned or not responded to previous treatments. It targets GD2, a disialoganglioside found on neuroblastoma cells, helping to slow disease progression when combined with GM-CSF. This therapy is typically reserved for high-risk cases under close medical supervision. Patients and caregivers often ask 'what is naxitamab used for' when researching treatment options.

Side Effects

  • During treatment, patients may experience infusion-related reactions including fever, low blood pressure, or allergic responses, which are typically managed with premedications. Some individuals report fatigue, pain, or gastrointestinal discomfort following administration. These effects vary by patient and should be monitored by healthcare providers throughout therapy.

Precautions & Warnings

  • Naxitamab requires careful handling and administration by healthcare professionals in a controlled setting. Patients should disclose all medications and medical conditions to their provider before starting treatment. Regular monitoring of vital signs and blood counts is essential during therapy. Keep vials refrigerated between 2-8°C and protect from light until use.

Avoid Interactions

  • No specific drug interactions have been definitively established with naxitamab, though caution is advised when combining with other agents affecting blood pressure or immune responses. Patients should inform their doctor about all prescription drugs, over-the-counter medications, and supplements. Avoid live vaccines during treatment without consulting a healthcare provider.

References

Frequently Asked Questions

Naxitamab is used to treat relapsed or refractory high-risk neuroblastoma in pediatric patients when combined with GM-CSF.

It is given as an intravenous infusion in a healthcare setting by medical professionals.

Common effects include infusion reactions like fever or low blood pressure, fatigue, and pain.

Naxitamab is approved specifically for pediatric patients with neuroblastoma; use in adults is not established.

Store vials refrigerated between 2-8°C and protect from light until administration.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naxitamab

Danyelza 40mg

Danyelza 40mg

40mg/10ml Vials

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT